Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
Seung Tae Kim, Kyong Hwa Park, Sang Won Shin, Yeul Hong Kim
Cancer Res Treat. 2014;46(1):48-54.   Published online 2014 Jan 15     DOI:
Citations to this article as recorded by Crossref logo
Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Italia Falcone, Francesco Cognetti, Michele Milella, Ludovica Ciuffreda
Journal of Oncology.2019; 2019: 1.     CrossRef
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis
Javier Garde Noguera, Eloisa Jantus-Lewintre, Mireia Gil-Raga, Elena Evgenyeva, Sonia Maciá Escalante, Antonio Llombart-Cussac, Carlos Camps Herrero
Molecular and Clinical Oncology.2017; 6(3): 403.     CrossRef
MEK inhibitor can reverse the resistance to bevacizumab in A 549 cells harboring Kirsten rat sarcoma oncogene homolog mutation
Yuan Wang, Ping Yan, Zhentao Liu, Xiaodan Yang, Yaping Wang, Zhirong Shen, Hua Bai, Jie Wang, Zhijie Wang
Thoracic Cancer.2016; 7(3): 279.     CrossRef
Medullary carcinoma of the colon: can the undifferentiated be differentiated?
Anne-Marie Kanstrup Fiehn, Morten Grauslund, Anders Glenthøj, Linea Cecilie Melchior, Ben Vainer, Gro Linno Willemoe
Virchows Archiv.2015; 466(1): 13.     CrossRef
CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest
Wen Pan, Yingying Cheng, Heyu Zhang, Baocai Liu, Xiaoning Mo, Ting Li, Lin Li, Xiaojing Cheng, Lianhai Zhang, Jiafu Ji, Pingzhang Wang, Wenling Han
Scientific Reports.2015;[Epub]     CrossRef
Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts
Hiroshi Tsukihara, Fumio Nakagawa, Kazuki Sakamoto, Keiji Ishida, Nozomu Tanaka, Hiroyuki Okabe, Junji Uchida, Kenichi Matsuo, Teiji Takechi
Oncology Reports.2015;[Epub]     CrossRef